Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Drug Discovery & Development
Immuno Oncology Investigations: The NKG2D Pathway, Diagnostic Biomarker, and Allogenic CAR Ts
Cell UK 2021 hosts experts in cell and immunotherapy working towards new diagnostic tools and therapies.
In Conversation With Pedro Caetano Pinto, Lab Lead in Experimental Urology, Universität Greifswald
We interview Pedro-Caetano Pinto, Lab Head at the University of Greifswald to learn more about his work with microphysiological systems for advanced kidney and prostate cancer research.
Drug Discovery & Development
Express Your Cells: Enhancing T Cell Function with Small Molecule HPK1 Inhibitors
Inhibiting the HPK1 pathway can enhance the cancer killing function of T lymphocytes. RAPT Therapeutics showcases a series of small molecules to do this.
NextGen Therapeutics
Retinal Disease Drug Receives Approval from European Commission
Ranivisio is a biosimilar of Lucentis which treats serious retinal diseases.
Q and A with Vasiliki E. Kalodimou
Vasiliki Kalodimou of the NCSR DEMOKRITOS, discusses her work in cell therapy analytics, ahead of Oxford Global's Cell Therapy Analytics Event.
Using Humanised Mice to Evaluate Vaccine Efficacy
Kymab Ltd presents the utility of mice models for studying human immune response to complex vaccines.
Stem Cell Therapy
Combinatorial Culture Technology for Stem Cell Therapy Applications
How can combinatorial screening of diverse variables in process development optimise cell and gene therapies? Marina Tarunina, Research Director at Plasticell, investigates.
Drug Discovery & Development
iNKT Cells and Their Applications in Immuno-Oncology
The applications of iNKT cells as oncological therapeutics and remedial treatments are almost astoundingly diverse. Their capacity for moderation subject to their intended use makes them suited to a variety of therapeutic functions and applications.
Moderna Sues Pfizer and BioNTech over mRNA COVID-19 Vaccines
Why is Moderna suing Pfizer and BioNTech over its COVID-19 vaccine despite recent pledge?
mRNA Therapeutics: Learning from Preclinical Concepts to Ensure Clinical Translatability in Nanomedicinal Approaches
This Commentary article explores the applications of mRNA therapeutics in disease treatment and prevention. The commercial presence of microfluidics technologies has improved process development, and has helped to provide rapid development along with the existence of established formulation principles for vaccines.
Q & A with Vincent Dewar
We interview Vincent Dewar, Associate Director and Head of Immunoassay Analytical Research Development at GlaxoSmithKline, to learn more about the importance of immunoassays for vaccine development.
3D Cell Culture
Human Stem Cell Model Development for Neurodegenerative Diseases
How can the use of human stem cell models of neurodegenerative disease advance drug discovery? Clare Jones, Chief Scientific Officer at Talisman Therapeutics, investigates.